<?xml version="1.0" encoding="UTF-8"?><ns2:project xmlns:ns1="http://gtr.rcuk.ac.uk/gtr/api" xmlns:ns2="http://gtr.rcuk.ac.uk/gtr/api/project" xmlns:ns3="http://gtr.rcuk.ac.uk/gtr/api/fund" xmlns:ns4="http://gtr.rcuk.ac.uk/gtr/api/person" xmlns:ns5="http://gtr.rcuk.ac.uk/gtr/api/project/outcome" xmlns:ns6="http://gtr.rcuk.ac.uk/gtr/api/organisation" ns1:created="2026-07-08T08:44:08Z" ns1:href="http://gtr.ukri.org/gtr/api/projects/50983AA1-6865-4941-9BD1-F14F75FCB05E" ns1:id="50983AA1-6865-4941-9BD1-F14F75FCB05E"><ns1:links><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/persons/F83A89B0-926B-49E8-BDF5-FFDFA14D5D2A" ns1:rel="PM_PER"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/66C4134D-93CF-4589-BC15-F8BC872C7F52" ns1:rel="LEAD_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/B5C86DB8-4736-48A8-87D1-F9EB2A9CDE39" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:href="http://gtr.ukri.org/gtr/api/organisations/66C4134D-93CF-4589-BC15-F8BC872C7F52" ns1:rel="PARTICIPANT_ORG"/><ns1:link ns1:end="2022-01-31T00:00:00Z" ns1:href="http://gtr.ukri.org/gtr/api/funds/11E51846-990A-4069-9669-33819F0C707A" ns1:rel="FUND" ns1:start="2020-09-30T23:00:00Z"/></ns1:links><ns2:identifiers><ns2:identifier ns2:type="RCUK">47612</ns2:identifier></ns2:identifiers><ns2:title>The development of a new, highly-efficacious, 100% natural, anti-viral active ingredient</ns2:title><ns2:status>Closed</ns2:status><ns2:grantCategory>Study</ns2:grantCategory><ns2:leadFunder>Innovate UK</ns2:leadFunder><ns2:abstractText>Despite rapid advances in healthcare and medical technology, viruses continue to pose a major threat to human, animal and plant health, costing economies hundreds of billions each year. Easily transmitted and immune to antibiotics, viruses (particularly non-enveloped) such as Norovirus, Polio virus and Adenovirus are very difficult to eradicate and even more expensive to treat through a limited number of antiviral solutions (&amp;pound;53.9bn global spend by 2025 [Grandview Research][0]). Norovirus alone kills 219k people per annum and sickens nearly 700m globally, costing &amp;pound;44bn per year in healthcare and lost productivity (&amp;pound;115m NHS cost pa) ([Telegraph][1]). Furthermore, they are becoming increasingly resistant to the current antiviral agents.

Leading state of the art antiviral solutions on the market are either based upon bleach (5% active, synthetic, corrosives, hazardous to touch) or ethanol (c60% active, synthesised, requires high concentration, short-lasting benefit, dries skin out).

Working in close partnership with the Department of Virology at Manchester University and based upon 4 years of research, we intend to explore and harness the highly efficacious properties of seaweed as a new, 100% natural, sustainable antiviral active ingredient for cleaning products (medium term) and medicines (long term).

[0]: https://www.grandviewresearch.com/press-release/global-antiviral-drugs-market
[1]: https://www.telegraph.co.uk/news/2016/04/26/norovirus-costs-the-world-some-44-billion-per-year-says-new-stud/</ns2:abstractText></ns2:project>